Nov 30 (Reuters) - Mayne Pharma Group Ltd (MYX) :
- FOCUSED ON DRIVING IMPROVED PROFITABILITY AND CASH FLOW WITH RETURN TO POSITIVE EBITDA EXPECTED IN FY24
Nov 30 (Reuters) - Mayne Pharma Group Ltd (MYX) : FOCUSED ON...
Add to My Watchlist
What is My Watchlist?